Regional differences in health care of patients with inflammatory bowel disease in Germany

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autoren

  • Ansgar Lange
  • Anne Prenzler
  • Oliver Bachmann
  • Roland Linder
  • Sarah Neubauer
  • Jan Zeidler
  • Michael P. Manns
  • J. Matthias von der Schulenburg

Externe Organisationen

  • Medizinische Hochschule Hannover (MHH)
  • Wissenschaftliches Institut der TK für Nutzen und Effizienz im Gesundheitswesen (WINEG)
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Aufsatznummer29
FachzeitschriftHealth Economics Review
Jahrgang5
PublikationsstatusVeröffentlicht - 16 Okt. 2015

Abstract

Background: The regional availability of specialized physicians is an important aspect in healthcare of patients with IBD. The association between physician density and healthcare is not yet clear. Most studies did not consider district type, which reflects population density. Our research question was, “Do specialist density and district type influence the healthcare of IBD patients in Germany?” Methods: We combined a claims dataset from a German health insurance fund with population and physician data. Four main aspects were investigated: regular specialist visits, drug therapies, surveillance colonoscopy, and IBD-related hospitalizations. Various regression analyses were performed. Results: The study cohort was comprised of 21,771 individuals, including 9282 patients with Crohn disease and 12,489 patients with ulcerative colitis. Patients who were living in districts with higher specialist densities were more likely to attend specialist visits on a regular basis. No difference in the frequencies of TNF-alpha inhibitor therapies was found. However, individuals from urban areas were more likely to receive a permanent immunosuppressive therapy with continuous specialist support. Conclusions: The results revealed that some aspects had positive effects on the probability of implementing healthcare in accordance with pathways and guidelines. No clear evidence of a general healthcare undersupply in rural areas was found.

ASJC Scopus Sachgebiete

Ziele für nachhaltige Entwicklung

Zitieren

Regional differences in health care of patients with inflammatory bowel disease in Germany. / Lange, Ansgar; Prenzler, Anne; Bachmann, Oliver et al.
in: Health Economics Review, Jahrgang 5, 29, 16.10.2015.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Lange, A, Prenzler, A, Bachmann, O, Linder, R, Neubauer, S, Zeidler, J, Manns, MP & von der Schulenburg, JM 2015, 'Regional differences in health care of patients with inflammatory bowel disease in Germany', Health Economics Review, Jg. 5, 29. https://doi.org/10.1186/s13561-015-0067-1
Lange, A., Prenzler, A., Bachmann, O., Linder, R., Neubauer, S., Zeidler, J., Manns, M. P., & von der Schulenburg, J. M. (2015). Regional differences in health care of patients with inflammatory bowel disease in Germany. Health Economics Review, 5, Artikel 29. https://doi.org/10.1186/s13561-015-0067-1
Lange A, Prenzler A, Bachmann O, Linder R, Neubauer S, Zeidler J et al. Regional differences in health care of patients with inflammatory bowel disease in Germany. Health Economics Review. 2015 Okt 16;5:29. doi: 10.1186/s13561-015-0067-1
Lange, Ansgar ; Prenzler, Anne ; Bachmann, Oliver et al. / Regional differences in health care of patients with inflammatory bowel disease in Germany. in: Health Economics Review. 2015 ; Jahrgang 5.
Download
@article{c8bc032b8efc4c01a0f3df99dc0aaec8,
title = "Regional differences in health care of patients with inflammatory bowel disease in Germany",
abstract = "Background: The regional availability of specialized physicians is an important aspect in healthcare of patients with IBD. The association between physician density and healthcare is not yet clear. Most studies did not consider district type, which reflects population density. Our research question was, “Do specialist density and district type influence the healthcare of IBD patients in Germany?” Methods: We combined a claims dataset from a German health insurance fund with population and physician data. Four main aspects were investigated: regular specialist visits, drug therapies, surveillance colonoscopy, and IBD-related hospitalizations. Various regression analyses were performed. Results: The study cohort was comprised of 21,771 individuals, including 9282 patients with Crohn disease and 12,489 patients with ulcerative colitis. Patients who were living in districts with higher specialist densities were more likely to attend specialist visits on a regular basis. No difference in the frequencies of TNF-alpha inhibitor therapies was found. However, individuals from urban areas were more likely to receive a permanent immunosuppressive therapy with continuous specialist support. Conclusions: The results revealed that some aspects had positive effects on the probability of implementing healthcare in accordance with pathways and guidelines. No clear evidence of a general healthcare undersupply in rural areas was found.",
keywords = "Crohn, Guidelines, Inflammatory bowel disease, Quality, Regional differences, Ulcerative colitis",
author = "Ansgar Lange and Anne Prenzler and Oliver Bachmann and Roland Linder and Sarah Neubauer and Jan Zeidler and Manns, {Michael P.} and {von der Schulenburg}, {J. Matthias}",
note = "Funding Information: This study was funded by the German Research Foundation (DFG).",
year = "2015",
month = oct,
day = "16",
doi = "10.1186/s13561-015-0067-1",
language = "English",
volume = "5",

}

Download

TY - JOUR

T1 - Regional differences in health care of patients with inflammatory bowel disease in Germany

AU - Lange, Ansgar

AU - Prenzler, Anne

AU - Bachmann, Oliver

AU - Linder, Roland

AU - Neubauer, Sarah

AU - Zeidler, Jan

AU - Manns, Michael P.

AU - von der Schulenburg, J. Matthias

N1 - Funding Information: This study was funded by the German Research Foundation (DFG).

PY - 2015/10/16

Y1 - 2015/10/16

N2 - Background: The regional availability of specialized physicians is an important aspect in healthcare of patients with IBD. The association between physician density and healthcare is not yet clear. Most studies did not consider district type, which reflects population density. Our research question was, “Do specialist density and district type influence the healthcare of IBD patients in Germany?” Methods: We combined a claims dataset from a German health insurance fund with population and physician data. Four main aspects were investigated: regular specialist visits, drug therapies, surveillance colonoscopy, and IBD-related hospitalizations. Various regression analyses were performed. Results: The study cohort was comprised of 21,771 individuals, including 9282 patients with Crohn disease and 12,489 patients with ulcerative colitis. Patients who were living in districts with higher specialist densities were more likely to attend specialist visits on a regular basis. No difference in the frequencies of TNF-alpha inhibitor therapies was found. However, individuals from urban areas were more likely to receive a permanent immunosuppressive therapy with continuous specialist support. Conclusions: The results revealed that some aspects had positive effects on the probability of implementing healthcare in accordance with pathways and guidelines. No clear evidence of a general healthcare undersupply in rural areas was found.

AB - Background: The regional availability of specialized physicians is an important aspect in healthcare of patients with IBD. The association between physician density and healthcare is not yet clear. Most studies did not consider district type, which reflects population density. Our research question was, “Do specialist density and district type influence the healthcare of IBD patients in Germany?” Methods: We combined a claims dataset from a German health insurance fund with population and physician data. Four main aspects were investigated: regular specialist visits, drug therapies, surveillance colonoscopy, and IBD-related hospitalizations. Various regression analyses were performed. Results: The study cohort was comprised of 21,771 individuals, including 9282 patients with Crohn disease and 12,489 patients with ulcerative colitis. Patients who were living in districts with higher specialist densities were more likely to attend specialist visits on a regular basis. No difference in the frequencies of TNF-alpha inhibitor therapies was found. However, individuals from urban areas were more likely to receive a permanent immunosuppressive therapy with continuous specialist support. Conclusions: The results revealed that some aspects had positive effects on the probability of implementing healthcare in accordance with pathways and guidelines. No clear evidence of a general healthcare undersupply in rural areas was found.

KW - Crohn

KW - Guidelines

KW - Inflammatory bowel disease

KW - Quality

KW - Regional differences

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=84971330601&partnerID=8YFLogxK

U2 - 10.1186/s13561-015-0067-1

DO - 10.1186/s13561-015-0067-1

M3 - Article

AN - SCOPUS:84971330601

VL - 5

JO - Health Economics Review

JF - Health Economics Review

SN - 2191-1991

M1 - 29

ER -